BIO-Key International Forecasts 7-Cent Loss Per Share, Revenue Expected to Surge 50%
BKYI sits 16% above its 52-week low of $0.509.
Summary
Analysts anticipate BIO-Key International will report a loss of 7 cents per share for the quarter ending December 31, 2025, when it releases results on March 31. Despite the projected loss, the company is also expected to show a significant 50.5% increase in quarterly revenue, reaching $2.2 million. This earnings preview provides critical expectations for a micro-cap company, setting the stage for the upcoming report. Traders will closely monitor the actual results against these estimates, weighing the continued unprofitability against the strong top-line growth. The actual Q4 2025 earnings release will be the next major catalyst.
At the time of this announcement, BKYI was trading at $0.59 on NASDAQ in the Technology sector, with a market capitalization of approximately $6.4M. The 52-week trading range was $0.51 to $1.97. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.